Summary
158.76 -0.95(-0.59%)05/15/2024
Celanese Corp (CE)
Celanese Corp (CE)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 2.29 | 5.94 | -1.32 | 9.21 | 39.60 | 53.50 | 266.31 | 327.54 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 162.73 | |
| Open | 159.98 | |
| High | 163.89 | |
| Low | 159.98 | |
| Volume | 608,370 | |
| Change | 3.65 | |
| Change % | 2.29 | |
| Avg Volume (20 Days) | 452,665 | |
| Volume/Avg Volume (20 Days) Ratio | 1.34 | |
| 52 Week Range | 99.33 - 172.16 | |
| Price vs 52 Week High | -5.48% | |
| Price vs 52 Week Low | 63.83% | |
| Range | 1.72 | |
| Gap Up/Down | 0.87 | |
Fundamentals | ||
| Market Capitalization (Mln) | 17,818 | |
| EBIDTA | 2,042,000,000 | |
| PE Ratio | 24.2774 | |
| PEG Ratio | 0.5917 | |
| WallStreet Target Price | 195.09 | |
| Book Value | 35.8950 | |
| Earnings Per Share | 24.6167 | |
| EPS Estimate Current Quarter | 4.7000 | |
| EPS Estimate Next Quarter | 3.6700 | |
| EPS Estimate Current Year | 18.3200 | |
| EPS Estimate Next Year | 15.7200 | |
| Diluted EPS (TTM) | 24.7920 | |
| Revenues | ||
| Profit Marging | 0.3590 | |
| Operating Marging (TTM) | 0.2139 | |
| Return on asset (TTM) | 0.0984 | |
| Return on equity (TTM) | 88.2838 | |
| Revenue TTM | 7,853,000,192 | |
| Revenue per share TTM | 69.5040 | |
| Quarterly Revenue Growth (YOY) | 0.6060 | |
| Quarterly Earnings Growth (YOY) | 1.6120 | |
| Gross Profit (TTM) | 1,293,000,000 | |
| Dividends | ||
| Dividend Share | 2.6600 | |
| Dividend Yield | 0.0168 | |
| Valuations | ||
| Trailing PE | 6.4372 | |
| Forward PE | 10.1626 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 4.4704 | |
| Revenue Enterprise Value | 2.5736 | |
| EBITDA Enterprise Value | 5.4097 | |
| Shares | ||
| Shares Outstanding | 108,871,000 | |
| Shares Float | 108,582,340 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.20 | |
| Institutions (%) | 95.21 | |
05/09 08:46 EST - Zacks Investment Research
Celanese's (CE) Q1 Earnings Surpass Estimates, Sales Lag
Net sales of Engineered Materials unit of Celanese (CE) decrease sequentially on lower volumes and prices in Q1.
Celanese's (CE) Q1 Earnings Surpass Estimates, Sales Lag
Net sales of Engineered Materials unit of Celanese (CE) decrease sequentially on lower volumes and prices in Q1.
05/08 19:01 EST - Zacks Investment Research
Celanese (CE) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Celanese (CE) Reports Q1 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
05/07 09:46 EST - Zacks Investment Research
Celanese (CE) to Report Q1 Earnings: What's in the Offing?
Celanese (CE) is expected to have benefited from cost-cutting and efficiency initiatives, as well as investments in high-return organic projects and acquisition synergies in Q1.
Celanese (CE) to Report Q1 Earnings: What's in the Offing?
Celanese (CE) is expected to have benefited from cost-cutting and efficiency initiatives, as well as investments in high-return organic projects and acquisition synergies in Q1.
05/03 10:21 EST - Zacks Investment Research
Countdown to Celanese (CE) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top -and-bottom-line estimates for Celanese (CE), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Countdown to Celanese (CE) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS
Besides Wall Street's top -and-bottom-line estimates for Celanese (CE), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
05/01 11:05 EST - Zacks Investment Research
Analysts Estimate Celanese (CE) to Report a Decline in Earnings: What to Look Out for
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Celanese (CE) to Report a Decline in Earnings: What to Look Out for
Celanese (CE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
04/12 10:36 EST - Zacks Investment Research
Here's Why You Should Retain Celanese (CE) in Your Portfolio
While Celanese (CE) faces challenges from demand softness and pricing pressures, it benefits from strategic acquisitions and productivity measures.
Here's Why You Should Retain Celanese (CE) in Your Portfolio
While Celanese (CE) faces challenges from demand softness and pricing pressures, it benefits from strategic acquisitions and productivity measures.
04/11 10:26 EST - Zacks Investment Research
Celanese (CE) Achieves Milestones in the Acetyl Chain Business
Celanese (CE) achieves milestones in cost-effective, sustainable growth, including new facilities and supply contracts, positioning for earnings increase and global expansion.
Celanese (CE) Achieves Milestones in the Acetyl Chain Business
Celanese (CE) achieves milestones in cost-effective, sustainable growth, including new facilities and supply contracts, positioning for earnings increase and global expansion.
04/03 08:56 EST - Zacks Investment Research
Celanese (CE) Up 39% in 6 Months: What's Driving the Rally?
Celanese (CE) benefits from its productivity measures, investments in organic projects and strategic acquisitions.
Celanese (CE) Up 39% in 6 Months: What's Driving the Rally?
Celanese (CE) benefits from its productivity measures, investments in organic projects and strategic acquisitions.
03/25 12:11 EST - Zacks Investment Research
Celanese (CE) Gets ISCC-Certified for Low Carbon CCU Methanol
Celanese (CE) now offers low-carbon choices to customers across its Acetyl Chain and Engineered Materials products under the ECO-CC name.
Celanese (CE) Gets ISCC-Certified for Low Carbon CCU Methanol
Celanese (CE) now offers low-carbon choices to customers across its Acetyl Chain and Engineered Materials products under the ECO-CC name.
03/22 08:16 EST - Zacks Investment Research
Celanese (CE) and Secarna Partner for Antisense Therapies
Celanese's (CE) collaboration with Secarna enables the development of a novel implant with the potential to significantly alter how disease-modifying ASO treatments are given.
Celanese (CE) and Secarna Partner for Antisense Therapies
Celanese's (CE) collaboration with Secarna enables the development of a novel implant with the potential to significantly alter how disease-modifying ASO treatments are given.
03/21 12:36 EST - Zacks Investment Research
Why Is Celanese (CE) Up 10% Since Last Earnings Report?
Celanese (CE) reported earnings 30 days ago. What's next for the stock?
Why Is Celanese (CE) Up 10% Since Last Earnings Report?
Celanese (CE) reported earnings 30 days ago. What's next for the stock?
03/21 11:41 EST - Zacks Investment Research
Here's Why You Should Hold Onto Celanese (CE) Stock For Now
While Celanese (CE) faces headwinds from demand softness and pricing pressures, it gains on strategic acquisitions and productivity measures.
Here's Why You Should Hold Onto Celanese (CE) Stock For Now
While Celanese (CE) faces headwinds from demand softness and pricing pressures, it gains on strategic acquisitions and productivity measures.
03/10 20:36 EST - Seeking Alpha
Celanese: Appetite For Acquisitions Remains
Celanese's acquisition of DuPont's Mobility and Materials division did not bring the expected returns due to a challenging market environment. The company is currently saddled with a large debt and depressed earnings, but management is taking actions to ensure profitability and service the debt. While management is taking the right actions, the current perspective does not outweigh short-term risks.
Celanese: Appetite For Acquisitions Remains
Celanese's acquisition of DuPont's Mobility and Materials division did not bring the expected returns due to a challenging market environment. The company is currently saddled with a large debt and depressed earnings, but management is taking actions to ensure profitability and service the debt. While management is taking the right actions, the current perspective does not outweigh short-term risks.
03/04 07:15 EST - Zacks Investment Research
Celanese (CE) Announces Commercial Launch of Glaukos' iDose TR
iDose TR uses Celanese's (CE) VitalDose EVA. It is approved following the completion of two pivotal trials which demonstrates safety and efficacy.
Celanese (CE) Announces Commercial Launch of Glaukos' iDose TR
iDose TR uses Celanese's (CE) VitalDose EVA. It is approved following the completion of two pivotal trials which demonstrates safety and efficacy.
02/22 12:27 EST - InvestorPlace
7 Earnings Losers With a Shot at a Strong Comeback
While companies who rank among the earnings losers category don't obviously generate confidence, it's also important to keep in mind the big picture. Technology juggernaut Nvidia (NASDAQ: NVDA ) provides an extreme example of this.
7 Earnings Losers With a Shot at a Strong Comeback
While companies who rank among the earnings losers category don't obviously generate confidence, it's also important to keep in mind the big picture. Technology juggernaut Nvidia (NASDAQ: NVDA ) provides an extreme example of this.
02/21 13:56 EST - Seeking Alpha
Celanese Corporation (CE) Q4 2023 Earnings Call Transcript
Celanese Corporation (CE) Q4 2023 Earnings Call Transcript
Celanese Corporation (CE) Q4 2023 Earnings Call Transcript
Celanese Corporation (CE) Q4 2023 Earnings Call Transcript
02/21 09:46 EST - Zacks Investment Research
Celanese's (CE) Earnings and Revenues Miss Estimates in Q4
Pricing of Celanese's (CE) Engineered Material segment declines in Q4 due to tough competition and product mix challenges in the Americas and Europe.
Celanese's (CE) Earnings and Revenues Miss Estimates in Q4
Pricing of Celanese's (CE) Engineered Material segment declines in Q4 due to tough competition and product mix challenges in the Americas and Europe.
02/20 19:30 EST - Zacks Investment Research
Celanese (CE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Celanese (CE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
02/20 18:30 EST - Zacks Investment Research
Celanese (CE) Q4 Earnings and Revenues Miss Estimates
Celanese (CE) came out with quarterly earnings of $2.24 per share, missing the Zacks Consensus Estimate of $2.29 per share. This compares to earnings of $1.44 per share a year ago.
Celanese (CE) Q4 Earnings and Revenues Miss Estimates
Celanese (CE) came out with quarterly earnings of $2.24 per share, missing the Zacks Consensus Estimate of $2.29 per share. This compares to earnings of $1.44 per share a year ago.
02/20 12:41 EST - Zacks Investment Research
CE or BCPC: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Celanese (CE) and Blachem (BCPC). But which of these two stocks is more attractive to value investors?
CE or BCPC: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Chemical - Specialty sector have probably already heard of Celanese (CE) and Blachem (BCPC). But which of these two stocks is more attractive to value investors?